JP2006517951A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517951A5
JP2006517951A5 JP2006502029A JP2006502029A JP2006517951A5 JP 2006517951 A5 JP2006517951 A5 JP 2006517951A5 JP 2006502029 A JP2006502029 A JP 2006502029A JP 2006502029 A JP2006502029 A JP 2006502029A JP 2006517951 A5 JP2006517951 A5 JP 2006517951A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
hydrogen
hydroxy
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006502029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517951A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/050135 external-priority patent/WO2004074289A1/en
Publication of JP2006517951A publication Critical patent/JP2006517951A/ja
Publication of JP2006517951A5 publication Critical patent/JP2006517951A5/ja
Withdrawn legal-status Critical Current

Links

JP2006502029A 2003-02-18 2004-02-16 6−置換イミダゾピラジン Withdrawn JP2006517951A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003652 2003-02-18
PCT/EP2004/050135 WO2004074289A1 (en) 2003-02-18 2004-02-16 6-substituted imidazopyrazines

Publications (2)

Publication Number Publication Date
JP2006517951A JP2006517951A (ja) 2006-08-03
JP2006517951A5 true JP2006517951A5 (enExample) 2007-03-22

Family

ID=32892854

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006502029A Withdrawn JP2006517951A (ja) 2003-02-18 2004-02-16 6−置換イミダゾピラジン

Country Status (19)

Country Link
US (1) US20060148796A1 (enExample)
EP (1) EP1599481A1 (enExample)
JP (1) JP2006517951A (enExample)
KR (1) KR20050100396A (enExample)
CN (1) CN1747956A (enExample)
AR (1) AR043002A1 (enExample)
AU (1) AU2004213177A1 (enExample)
BR (1) BRPI0407390A (enExample)
CA (1) CA2516021A1 (enExample)
EA (1) EA200501229A1 (enExample)
HR (1) HRP20050794A2 (enExample)
IS (1) IS8015A (enExample)
MX (1) MXPA05008582A (enExample)
NO (1) NO20054199L (enExample)
PL (1) PL376466A1 (enExample)
RS (1) RS20050619A (enExample)
TW (1) TW200504068A (enExample)
WO (1) WO2004074289A1 (enExample)
ZA (1) ZA200505670B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028051A2 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
CA2654202A1 (en) * 2006-06-06 2007-12-21 Schering Corporation Imidazopyrazines as protein kinase inhibitors
US20090175852A1 (en) 2006-06-06 2009-07-09 Schering Corporation Imidazopyrazines as protein kinase inhibitors
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
GB0716292D0 (en) 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
KR101743784B1 (ko) 2008-12-08 2017-06-05 질레드 코네티컷 인코포레이티드 이미다조피라진 syk 억제제
KR101745732B1 (ko) * 2008-12-08 2017-06-12 질레드 코네티컷 인코포레이티드 이미다조피라진 syk 억제제
ES2530449T3 (es) 2010-03-11 2015-03-02 Gilead Connecticut Inc Inhibidores de Syk de imidazopiridinas
CN116178295A (zh) * 2023-01-28 2023-05-30 山东亿盛实业股份有限公司 一种苯唑草酮代谢物t283的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
JPH07242666A (ja) * 1994-03-08 1995-09-19 Fujisawa Pharmaceut Co Ltd 複素環化合物
SE9704404D0 (sv) * 1997-11-28 1997-11-28 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
EP1363702A4 (en) * 2001-01-30 2007-08-22 Cytopia Pty Ltd PROCESS FOR INHIBITING KINASES

Similar Documents

Publication Publication Date Title
JP2009515980A5 (enExample)
JP2009516653A5 (enExample)
EP2397476A3 (en) Indole derivative having PGD2 receptor antagonist activity
JP2012510989A5 (enExample)
JP2010501478A5 (enExample)
JP2011528658A5 (enExample)
CA2582734A1 (en) Dimeric small molecule potentiators of apoptosis
JP2008510828A5 (enExample)
JP2009515887A5 (enExample)
JP2008543886A5 (enExample)
Yu et al. Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation
JP2016507502A5 (enExample)
NO20060082L (no) Indol azaindol og relaterte heterosykliske N-substituerte piperazinderivater
JP2012509263A5 (enExample)
CN101516876A (zh) 具有乙硫异烟胺活性增强作用的化合物及其用途
JPWO2012144463A1 (ja) 腫瘍治療剤
Han et al. Discovery of potent and selective CDK8 inhibitors through FBDD approach
JP2008511586A5 (enExample)
JP2016508135A5 (enExample)
JP2005517643A5 (enExample)
JP2005506298A5 (enExample)
JP2017119702A5 (enExample)
JP2014507412A5 (enExample)
JP2005533801A5 (enExample)
JP2012513982A5 (enExample)